Doctor Oh Hyun-Dong, a member of the Ministry of Food and Drug Safety’s IRB, the Institutional Review Board for clinical trials, was one of Young-Joon’s supporters. Of course, being a supporter didn’t mean that he was going to be generous in granting clinical approval for Young-Joon’s work; it just meant that he admired the brilliance of the future that a genius like him was building.0

Recently, there had been no new clinical trial requests from A-Bio, but this was inevitable. The latest cancer research Young-Joon had done was going to be reviewed by the FDA as it was done in America. The research he had done at the Karolinska Institute in Sweden skipped clinical trials.0

‘They technically should have done a clinical trial for that, too.’0

It didn’t really matter because the patient strongly asked for it, and the government approved of it with the recommendation from the Swedish Crown. Besides, what could the Ministry of Food and Drug Safety in Korea say about something that happened in Sweden?0

Cultured meat was also developed in the United States, and Young-Joon had already proven its safety when he was there. Also, because...0